Synopsis
This presentation will provide an overview of current
techniques for liver iron quantification, with a focus on relevant confounding
factors which may decrease the accuracy and reproducibility of LIC
estimates. The effect of these
confounders, as well as recent efforts to address them, will be presented. Educational Objectives
* Understand the main effects of iron
deposition on MR signals
* Become
familiar with the major MR-based techniques to quantify liver iron
* Appreciate the challenges associated with
quantifying liver iron, and the techniques designed to overcome these
challenges
Need
for Accurate, Non-Invasive Liver Iron Quantification
Excess iron accumulation in the
body, due to excess intestinal absorption (hemochromatosis) or multiple blood
transfusions (hemosiderosis), is toxic and can cause multiple health
complications including liver and heart damage, pancreatic dysfunction, and
growth failure. Oral chelation treatments are commonly prescribed to reduce
body iron content, but they are expensive (~$50,000/year) and have side
effects. Assessment of body iron levels is necessary for detection and
quantitative staging of iron overload, and monitoring of iron-reducing
treatments.
The
simplest method to assess body iron content is based on measuring serum
ferritin concentration from a blood sample. However, ferritin is confounded by
a number of factors (e.g. inflammation) and often does not accurately reflect
iron levels(1). In
contrast, measurement of liver iron concentration (LIC) is well known to be a
reliable indicator of total body iron(2). Liver biopsy can
provide accurate measurement of LIC, however it is invasive, suffers from high
sampling variability(3), and
is contraindicated in many patients due to the risk of uncontrolled bleeding.
MRI Techniques for Liver Iron Quantification
MRI is highly sensitive to the presence of iron in tissue.
Iron stores, typically in the form of ferritin
and hemosiderin, shorten the relaxation times T2, T2* and T1 (ie: increase in
the relaxation rates R2, R2* and R1, respectively). The most prominent effect
of iron is increasing R2 and R2* relaxation rates(4): R2 (as measured using single spin echo acquisitions with increasing
echo times) increases monotonically (although not linearly) in the presence of
liver iron deposits. This effect of iron on R2 is not completely understood,
but likely due in part to the diffusion of protons in areas of microscopic B0 field
inhomogeneities introduced by iron particles (ie: effective diffusion weighting
introduced by iron). These microscopic B0 inhomogeneities also cause rapid
signal dephasing in gradient echo acquisitions, resulting in increased R2*. The
relationship between LIC and R2* has been shown to be linear, although several
calibrations have been produced.
A number of techniques have been proposed for liver iron
quantification, largely based on one of the following three approaches:
* Signal
Intensity Ratio (SIR): In
SIR methods, the signal intensity of the liver on spin-echo (SE) or gradient-echo
(GRE) sequences is divided by the signal intensity of a reference tissue that
does not accumulate iron, such as fat or skeletal muscle, or air outside the
body (i.e., image noise) (5-7). Images are acquired using a body coil
to avoid sensitivity variations arising from surface coils (8). Large
regions-of-interest (ROIs) are placed in the reference object and the liver on
the same slice, and the ratio of the mean signals is calculated. The most
widely used SIR method is the one described by Gandon and colleagues (8).
* R2
relaxometry: In R2 relaxometry methods, several spin
echo images (either single spin echoes or as an echo train) are acquired and the
R2 relaxation rate is estimated. The most widely used R2 based method was
proposed by St Pierre et al (9). The St Pierre method uses five T2-weighted
single spin-echo (SSE) free-breathing sequences with constant repetition time
(TR) and increasing TE spaced at 3-ms intervals (TEs=6,9,12,15,18ms). Using
this method, a nonlinear relationship between R2 and LIC was calibrated (using
biopsy-determined LIC as the reference) in over 100 subjects. The main
challenge for spin-echo based R2 techniques is likely the need for relatively
long acquisition times.
* R2*
relaxometry: R2* relaxometry, based on gradient echo
acquisitions, has the potential to overcome some of the limitations of R2-based
techniques, due to its ability to provide full liver coverage without motion
artifacts within a single breath-hold. R2* relaxometry is typically based on 2D
or 3D spoiled gradient echo (SPGR) multi-echo sequences. These sequences can
acquire all echoes in each TR using an echo train (either with monopolar or
bipolar readout), a single echo per TR, or a combination of the two (ie:
multiple interleaved echo trains). Subsequently, R2* is measured from the rate
of exponential signal decay of the gradient echo signal.
Confounders to Liver Iron Quantification
The liver iron quantification techniques described above
are sensitive to a number of confounding factors, which can introduce bias and
decreased reproducibility into the LIC estimates. This presentation will
provide an overview of the relevant confounders for quantification of LIC,
including the following:
* Motion:
Motion, particularly due to respiration, can introduce
significant image artifacts, which can result in bias in the estimated LIC.
Motion is a particular concern in spin echo acquisitions (eg: for R2 mapping)
due to the long acquisition times.
* Fat:
Hepatic fat
accumulation is a very common condition (10). In the presence of water and fat
signal components, the signal acquired at a single voxel is not a simple
monoexponential decay, but instead contains oscillations as water and fat
signals become in and out of phase. These oscillations lead to errors in
fat-uncorrected R2* estimation using an exponential signal model, and these
errors depend heavily on the choice of TE combination.
* Macroscopic
B0 inhomogeneities: The presence of intra-voxel background
field variations introduces additional signal decay in R2* mapping
acquisitions. This additional signal decay can result in significant bias in
R2* measurements, particularly near tissue-air interfaces such as near the dome
of the liver.
* High
LIC (Noise effects): Liver R2 or R2* relaxometry is challenging in
the presence of very high LIC, due to the extremely rapid signal decay. R2*
relaxometry is particularly challenging, as R2* relaxation rates can surpass
1000 s-1 (T2*<1ms) at 1.5T in patients with high LIC. Accurate
R2*-based estimation of LIC over a wide range of liver iron levels requires
acquisition of short echo times and the use of optimized estimation techniques.
Recent efforts for the development of ultra-short TE R2* mapping techniques may
enable R2*-based LIC quantification with improved dynamic range.
* Field
strength dependence: Relaxation parameters vary with field
strength, therefore calibrations between R2 or R2* and LIC are field strength
specific. Further, certain LIC quantification challenges (eg: related to high
LIC) are increased at 3T relative to 1.5T due to the increased R2 and R2*.
Acknowledgements
We acknowledge the
support of NIH (research grants R01DK083380, R01DK088925, R01DK100651, K24
DK102595, UL1TR00427), and GE Healthcare.References
1. Nielsen
P, Gunther U, Durken M, Fischer R, Dullmann J. Serum ferritin iron in iron
overload and liver damage: correlation to body iron stores and diagnostic
relevance. J Lab Clin Med 2000;135:413-418.
2. Brittenham
GM, Badman DG. Noninvasive measurement of iron: report of an NIDDK workshop.
Blood 2003;101:15-19.
3. Ratziu V,
Charlotte F, Heurtier A, Gombert S, Giral P, Bruckert E, Grimaldi A, Capron F,
Poynard T. Sampling variability of liver biopsy in nonalcoholic fatty liver
disease. Gastroenterology 2005;128:1898-1906.
4. Ghugre NR,
Wood JC. Relaxivity-iron calibration in hepatic iron overload: probing
underlying biophysical mechanisms using a Monte Carlo model. Magn Reson Med
2011;65:837-847.
5. Gandon Y,
Guyader D, Heautot JF, Reda MI, Yaouanq J, Buhe T, Brissot P, Carsin M,
Deugnier Y. Hemochromatosis: diagnosis and quantification of liver iron with
gradient-echo MR imaging. Radiology 1994;193:533-538.
6. Ernst O, Sergent
G, Bonvarlet P, Canva-Delcambre V, Paris JC, L'Hermine C. Hepatic iron
overload: diagnosis and quantification with MR imaging. AJR Am J Roentgenol
1997;168:1205-1208.
7. Bonkovsky HL,
Rubin RB, Cable EE, Davidoff A, Rijcken TH, Stark DD. Hepatic iron concentration:
noninvasive estimation by means of MR imaging techniques. Radiology
1999;212:227-234.
8. Gandon Y,
Olivie D, Guyader D, Aube C, Oberti F, Sebille V, Deugnier Y. Non-invasive
assessment of hepatic iron stores by MRI. Lancet 2004;363:357-362.
9. St Pierre TG,
Clark PR, Chua-anusorn W, Fleming AJ, Jeffrey GP, Olynyk JK, Pootrakul P,
Robins E, Lindeman R. Noninvasive measurement and imaging of liver iron
concentrations using proton magnetic resonance. Blood 2005;105:855-861.
10. Szczepaniak
LS, Nurenberg P, Leonard D, Browning JD, Reingold JS, Grundy S, Hobbs HH,
Dobbins RL. Magnetic resonance spectroscopy to measure hepatic triglyceride
content: prevalence of hepatic steatosis in the general population. Am J
Physiol Endocrinol Metab 2005;288:E462-468.